SCOPUS 정보 검색 플랫폼

Volumn 162, Issue 11, 2002, Pages 1293-1300

Cevimeline for the treatment of xerostomia in patients with Sjögren syndrome: A randomized trial

(7) Fife, Rose S a Chase, Walter F g Dore, Robin K b Wiesenhutter, Craig W c Lockhart, Peter B d Tindall, Elizabeth e Suen, James Y f

a INDIANA UNIVERSITY SCHOOL OF MEDICINE (United States)

b UNIVERSITY OF CALIFORNIA (United States)

c Coeur d'Alene Arthritis Clinic ^* (United States)

d CAROLINAS MEDICAL CENTER (United States)

e OREGON HEALTH AND SCIENCE UNIVERSITY (United States)

f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES (United States)

g NONE

Author keywords

[No Author keywords available]

Indexed keywords

CEVIMELINE; CHOLINERGIC RECEPTOR STIMULATING AGENT; SALIVA SUBSTITUTE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG INDUCED DISEASE; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND DISEASE; SALIVATION; SJOEGREN SYNDROME; SYMPTOM; TREATMENT OUTCOME; XEROSTOMIA;

EID: 0037054022 PISSN: 00039926 EISSN: None Source Type: Journal
DOI: 10.1001/archinte.162.11.1293 Document Type: Article

Times cited : (162)

References (12)

1
- 0008577234
- Sjögren's syndrome
- Fauci AS, Martin JB, Braunwald E, et al, eds. New York, NY: McGraw-Hill Co
- (1998) Harrison's Principles of Internal Medicine. 14th ed. , pp. 1901-1904
- Moutsopoulos, H.M.¹

2
- 0026757493
- Salivary and oral components of Sjögren's syndrome
- (1992) Rheum Dis Clin North Am , vol.18 , pp. 571-589
- Daniels, T.E.¹ Fox, P.C.²

3
- 0032587876
- Sjögren's syndrome comes of age
- (1999) Semin Arthritis Rheum , vol.28 , pp. 355-359
- Anaya, J.M.¹ Talal, N.²

4
- 0001236848
- Sialogogic activities and histopathological observation of SNI-2011 in salivary glands of rat and mouse: Identification of a potential therapeutic agent for treatment of Siögren's syndrome
- August 11 -13; Tokyo, Japan
- (1993) Proceedings of the 4th International Symposium: Sjögren's Syndrome - State of the Art
- Iwabuchi, Y.¹ Katagiri, M.² Masuhara, T.³

5
- 0028006504
- Sialogogic activities of SNI-2011 compared with those of pilocarpine and McN-A-343 in rat salivary glands: Identification of a potential therapeutic agent for treatment of Sjögren's syndrome
- (1994) Gen Pharmacol , vol.25 , pp. 123-129
- Iwabuchi, Y.¹ Masuhara, T.²

6
- 0001051238
- The pharmacological profile of cevimeline (SNI-2011): A novel muscarinic agonist for the treatment of xerostomia in various models
- (1998) Arthritis Rheum , vol.41
- Ninomiya, T.¹ Iga, Y.² Fukui, K.³

7
- 0000095876
- Randomized, placebo-controlled trial of SNI-2011, a novel M3 muscarinic receptor agonist, for the treatment of Sjögren's syndrome
- (1998) Arthritis Rheum , vol.41
- Fox, R.I.¹ Petrone, D.² Condemi, J.³ Fife, R.⁴ Delgin, P.⁵

8
- 0031593918
- (+/-)-cis-2-Methylspiro[1,3-oxathiolane-5,3′-quinuclidine] hydrochloride, hemihydrate (SNI-2011, cevimeline hydrochloride) induces saliva and tear secretions in rats and mice: The role of muscarinic acetylcholine receptors
- (1998) Jpn J Pharmacol , vol.78 , pp. 373-380
- Iga, Y.¹ Arisawa, H.² Ogane, N.³

9
- 0031578554
- Long-lasting salivation induced by a novel muscarinic receptor agonist SNI-2011 in rats and dogs
- (1997) Eur J Pharmacol , vol.339 , pp. 1-9
- Masunaga, H.¹ Ogawa, H.² Uematsu, Y.³ Tomizuka, T.⁴ Yasuda, H.⁵ Takeshita, Y.⁶

10
- 0003133627
- Oral treatment and prevention of tooth decay
- Carsons S, Harris EK, eds. Oxford, England: Oxford University Press
- (1998) The New Sfögren's Syndrome Handbook , pp. 156-162
- Daniels, T.E.¹ Newbrun, E.²

11
- 0033063524
- The use of oral pilocarpine in xerostorma and Sjögren's syndrome
- (1999) Semin Arthritis Rheum , vol.28 , pp. 360-367
- Nusair, S.¹ Rubinow, A.²

12
- 0034617662
- Cevimeline (Evoxac) for dry mouth
- (2000) Med Lett Drugs Ther , vol.42 , pp. 70

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.